nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are protein–ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?
|
Llop-PeirĂł, Ariadna |
|
|
29 |
10 |
p. |
artikel |
2 |
Chemical coverage of human biological pathways
|
Kwak, Haejin Angela |
|
|
29 |
10 |
p. |
artikel |
3 |
Designed dualsteric modulators: A novel route for drug discovery
|
Li, Nuan |
|
|
29 |
10 |
p. |
artikel |
4 |
Exploration of inhibitors targeting KIF18A with ploidy-specific lethality
|
Chen, Qingsong |
|
|
29 |
10 |
p. |
artikel |
5 |
Hit me with your best shot: Integrated hit discovery for the next generation of drug targets
|
Ashraf, S. Neha |
|
|
29 |
10 |
p. |
artikel |
6 |
Innovative Strategies in Cancer Treatment: Harnessing Cuproptosis and Nanotechnology for Targeted Therapy
|
Dongsar, Tenzin Tsering |
|
|
29 |
10 |
p. |
artikel |
7 |
Machine learning and natural language processing in clinical trial eligibility criteria parsing: a scoping review
|
Kantor, Klaudia |
|
|
29 |
10 |
p. |
artikel |
8 |
Mechanical network motifs as targets for mechanomedicine
|
Lu, Mengnan |
|
|
29 |
10 |
p. |
artikel |
9 |
On the pivotal role of drug discovery in sustainable EU pharma reform
|
De Spiegeleer, Bart |
|
|
29 |
10 |
p. |
artikel |
10 |
Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegias
|
Sebastiano, Matteo Rossi |
|
|
29 |
10 |
p. |
artikel |
11 |
Promoting the social implementation of digital and mobile health: effects of regulation on user and non-user behavior in East Asia
|
Feng, Hanlin |
|
|
29 |
10 |
p. |
artikel |
12 |
Repurposing cardiac glycosides for anticancer treatment: a review of clinical studies
|
Nik Nabil, Wan Najbah |
|
|
29 |
10 |
p. |
artikel |
13 |
Role of long noncoding RNAs in the regulation of alternative splicing in glioblastoma
|
Yadav, Bhupender |
|
|
29 |
10 |
p. |
artikel |
14 |
Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy
|
Wang, Huiping |
|
|
29 |
10 |
p. |
artikel |